证券代码：688231 证券简称：隆达股份 公告编号：2025-049 江苏隆达超合金股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/10/13 | 2025/10/14 | 2025/10/14 | 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经江苏隆达超合金股份有限公司（以下简称"公司"）2025 年 5 月 16 日的2024年年度股东大会授权公司董事会制定实施，并经公司 2025 年 8 月 26 日召开的第二届董事会第十五次会议审议通过，具体情况如下： 2025 年 5 月 16 日，公司召开 2024 年年度股东大会，审议通过了《关于提请 股东大会授权董事会制定中期分红方案的议案》，同意授权公司董事会在满足现金 分红条件下，制定并实施 2025 年中期分红方案。 2025 年 8 月 26 日，公司召开第二届董事会第十五次会议， ...

Core Viewpoint - Jiangsu Longda Superalloy Co., Ltd. announced its 2025 semi-annual profit distribution plan, which was approved by the 2024 annual shareholders' meeting and the 15th meeting of the second board of directors [1] Summary by Relevant Sections - The record date for the distribution is set for October 13, 2025, with the ex-dividend date and cash dividend payment date on October 14, 2025 [1] - The company plans to distribute a cash dividend of 1.8 yuan (including tax) for every 10 shares held, without any capital reserve fund conversion into share capital or bonus shares [1] - As of the announcement date, the actual participating distribution shares amount to 241,546,345 shares, with a total proposed cash dividend of 43,478,342.1 yuan [1]

Market Overview - The Shanghai Composite Index closed at 3821.83 points, with a decline of 0.18% [1] - The total trading volume of A-shares reached 25,184.71 billion yuan [1] Technical Analysis - A total of 171 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Innovation Medical: 5-day MA at 22.60 yuan, 10-day MA at 23.25 yuan, a difference of -2.80% [1] - Xiangyu Medical: 5-day MA at 54.48 yuan, 10-day MA at 55.33 yuan, a difference of -1.54% [1] - Northern Long Dragon: 5-day MA at 122.21 yuan, 10-day MA at 123.92 yuan, a difference of -1.38% [1] Stock Performance - Key stocks with notable declines include: - Innovation Medical: down 2.97% with a turnover rate of 16.99% [1] - Xiangyu Medical: down 5.95% with a turnover rate of 2.14% [1] - Northern Long Dragon: down 2.23% with a turnover rate of 20.67% [1] - Other stocks with significant declines include: - Aorui: down 5.25% [1] - Changbai Mountain: down 7.15% [1] - Hengbao Shares: down 6.73% [1]

Market Overview - The Shanghai Composite Index closed at 3781.61 points, with a decline of 1.23% [1] - The total trading volume of A-shares reached 1713.539 billion yuan [1] Technical Analysis - A total of 228 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Innovation Medical: 5-day MA at 22.55 yuan, 10-day MA at 23.23 yuan, a difference of -2.92% [1] - North Long Dragon: 5-day MA at 121.67 yuan, 10-day MA at 123.65 yuan, a difference of -1.60% [1] - Xiangyu Medical: 5-day MA at 54.49 yuan, 10-day MA at 55.34 yuan, a difference of -1.53% [1] Individual Stock Performance - Significant declines in stock prices include: - Innovation Medical: down 4.27% with a turnover rate of 14.36% [1] - North Long Dragon: down 4.52% with a turnover rate of 13.85% [1] - Xiangyu Medical: down 5.86% with a turnover rate of 1.42% [1] - Other notable declines: - Shandong Mining Machine: down 4.43% [1] - Huakang Clean: down 6.50% [1] - Beautiful Ecology: down 5.15% [1] Additional Stock Data - The following stocks also showed significant declines: - Yuyin Co.: down 5.46% [2] - Kexin Information: down 5.22% [1] - Visual China: down 3.88% [1] - Stocks with notable trading activity include: - Hengbao: down 6.64% with a turnover rate of 10.88% [2] - Changbai Mountain: down 6.53% with a turnover rate of 4.05% [2]

证券代码：688231 证券简称：隆达股份 公告编号：2025-048 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 9 月 12 日 （二） 股东大会召开的地点：无锡市锡山区安镇街道翔云路 18 号，公司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： 江苏隆达超合金股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 | 1、出席会议的股东和代理人人数 | 87 | | --- | --- | | 普通股股东人数 | 87 | | 2、出席会议的股东所持有的表决权数量 | 140,400,723 | | 普通股股东所持有表决权数量 | 140,400,723 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 56.8752 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 56.8752 | （四 ...

北京大成(上海)律师事务所 关于江苏隆达超合金股份有限公司 2025 年第二次临时股东大会的 法律意见书 # DENTONS 大成 is Dentons' Preferred Law Firm in China. 北京大成(上海)律师事务所 www. dacheng.com 中国上海市世纪大道 100 号上海环球金融中心 9 层/24 层/25 层(200120) 9th/24th/25th Floor, Shanghai World Financial Center, 100 Century Avenue, Shanghai 200120, P. R. China Tel: +86 21-58785888 Fax: +86 21-58786866 北京大成(上海)律师事务所 关于江苏降达超合金股份有限公司 2025 年第二次临时股东大会的法律意见书 致:江苏隆达超合金股份有限公司 根据《中华人民共和国证券法》(以下简称"《证券法》")《中华人民共和国 公司法》(以下简称"《公司法》")和中国证券监督管理委员会《上市公司股东会 规则》(以下简称"《股东会规则》")等法律、法规和其他有关规范性文件的要 求,北京 ...

国信证券股份有限公司 一、持续督导工作情况 1 | | | 及其他规范性文件，切实履行其所 | | --- | --- | --- | | | | 做出的各项承诺 | | | 督导上市公司建立健全并有效执行公司治理制 | 保荐机构督促隆达股份依照相关 | | | 度，包括但不限于股东大会、董事会、监事会议 | 规定健全和完善公司治理制度，并 | | 7 | 事规则以及董事、监事和高级管理人员的行为规 | 严格执行，督导董事、监事、高级 | | | 范等 | 管理人员遵守行为规范 | | | 督导上市公司建立健全并有效执行内控制度，包 | 保荐机构对隆达股份的内控制度 | | | 括但不限于财务管理制度、会计核算制度和内部 | 的设计、实施和有效性进行了核 | | 8 | 审计制度，以及募集资金使用、关联交易、对外 | 查，隆达股份的内控制度符合相关 | | | 担保、对外投资、衍生品交易、对子公司的控制 | 法规要求并得到了有效执行，能够 | | | 等重大经营决策的程序与规则等 | 保证公司的规范运行 | | | 督导上市公司建立健全并有效执行信息披露制 | 保荐机构督促隆达股份严格执行 信息披露制度，审阅 ...

国联民生证券承销保荐有限公司 关于江苏隆达超合金股份有限公司 2025 年半年度持续督导跟踪报告 根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市 规则》《上海证券交易所上市公司自律监管指引第 11 号——持续督导》等有关法 律、法规及规范性文件的要求，国联民生证券承销保荐有限公司（以下简称"国 联民生保荐"或"保荐机构"）作为江苏隆达超合金股份有限公司（以下简称"隆达 股份"或"公司"）首次公开发行股票的保荐机构，对隆达股份进行持续督导，并出 具 2025 年半年度持续督导跟踪报告。 | 序号 | 工作内容 | 持续督导情况 | | --- | --- | --- | | 1 | 建立健全并有效执行持续督导工作制度，并针 | 保荐机构已建立健全并有效执行 | | | | 了持续督导制度，并制定了相应 | | | 对具体的持续督导工作制定相应的工作计划 | 的工作计划 | | 2 | 根据中国证监会相关规定，在持续督导工作开 | 保荐机构已与隆达股份签订《保 | | | 始前，与上市公司或相关当事人签署持续督导 | 荐协议》，该协议明确了双方在持 | | | 协议，明确双方在持续督导期间的权 ...

Group 1 - The core point of the article is that Longda Co., Ltd. has completed a share reduction plan by its shareholder Guolian Chantuo, reducing approximately 2.47 million shares, which accounts for 0.9997% of the company's total share capital [1][1][1] - As of the announcement date, Longda Co., Ltd. has a market capitalization of 4.9 billion yuan [1][1][1] Group 2 - For the fiscal year 2024, Longda Co., Ltd.'s revenue composition is as follows: aerospace accounts for 31.24%, other sectors 29.15%, gas turbines 19.18%, automotive turbines 7.21%, oil and gas chemicals 7.06%, and other businesses 6.16% [1][1][1]

Core Viewpoint - The announcement details the completion of a share reduction plan by a major shareholder of Jiangsu Longda Superalloy Co., Ltd, indicating a decrease in their ownership stake and the financial implications of this transaction [1][3]. Group 1: Major Shareholder Information - The major shareholder, Wuxi Guolian Industrial Upgrade Investment Center (Limited Partnership), held 21,556,321 shares, representing 8.73% of the total share capital before the reduction [1]. - The shares were acquired prior to the company's initial public offering (IPO) and became tradable on July 24, 2023 [1]. Group 2: Reduction Plan Implementation Results - The shareholder planned to reduce their holdings by no more than 1% of the total shares through centralized bidding, with the reduction price determined by market conditions [1]. - The actual reduction amounted to 2,467,738 shares, decreasing their holdings to 19,603,583 shares, which is 7.94% of the total share capital [1][2]. - The reduction period was from June 5, 2025, to September 4, 2025, with a total transaction value of approximately 47.16 million yuan, at a price range of 17.30 to 22.82 yuan per share [1][2]. Group 3: Compliance with Reduction Plan - The actual reduction was consistent with the previously disclosed reduction plan, and the plan was fully executed without any early termination [3].